According to South Korean media NEWSWIRE, on May 23rd, a gene editing and repair company called ToolGen, based in Seoul, signed a joint development agreement with the South Korean tobacco manufacturing and sales company KT&G to develop a high value-added tobacco correction system. The agreement is set to take effect on May 23, 2024.
The main purpose of this agreement is to develop new varieties of tobacco with specific reduced components and excellent taste using gene editing technology.
ToolGen's representative, Lee Byunghwa, stated, "ToolGen is utilizing gene editing technology to develop high-value seeds. We have obtained a biotechnology crop regulation exemption permit from the United States Department of Agriculture (USDA) for genetically repaired dwarf morning glory, soybeans, potatoes, etc., proving that we possess the highest level of technological capabilities globally. The two companies will engage in mutually beneficial cooperation in areas such as joint research, academic exchanges, and shared use of research equipment and facilities.
In addition, the agreement also stipulates that both parties will work together to develop new genetic resources and cultivate new varieties, and commercialize these new varieties.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
